Human multiple small cerebral infarcts are implicated in induction of stroke attacks and dementia associated with multiple brain embolism. These disorders were caused by permanent or prolonged occlusion of multiple microvascular in the brain. Unfortunately, few animal models can mimic clinical features in human multiple brain embolism. Recent evidences, however, suggest that microsphere embolism (ME)-induced ischemia model in rat resembles to multiple embolism or multi-infarct dementia in human with the clinical features.
Human multiple small cerebral infarcts are implicated in induction of stroke attacks and dementia associated with multiple brain embolism. These disorders were caused by permanent or prolonged occlusion of multiple microvascular in the brain. Unfortunately, few animal models can mimic clinical features in human multiple brain embolism. Recent evidences, however, suggest that microsphere embolism (ME)-induced ischemia model in rat resembles to multiple embolism or multi-infarct dementia in human with the clinical features. 2, 3) The cerebral multiple embolism is performed by injection of non-radioactive microsphere with a diameter ranging from 15 to 50 mm into the unilateral internal carotid artery in the rat. The light microscopic analysis or 2,3,5-triphenyltetrazolium chloride (TTC) staining shows widespread scattered infarct in the cerebral cortex, striatum and hippocampus of the ipsilateral hemisphere injected microsphere. The intra-arterial infusion of microsphere also leads blood-brain barrier disruption and cerebral vascular injury, thereby inducing severe brain edema. 4, 5) Furthermore, during and after ME-induced ischemia, abnormal intracellular signal transduction underlying detrimental metabolic and morphologic neuronal damages was observed. 6) However, little neurochemical events through nitric oxide (NO) production are known in the rodent multiple embolism model.
During cerebral ischemia, an abnormal elevation of intracellular Ca 2ϩ triggers activation of various Ca 2ϩ -dependent enzymes including endonucleases, proteases and phospholipases, thereby leading neuronal cell death. [7] [8] [9] [10] Among Ca 2ϩ -mediated cell death pathways, calmodulin (CaM) is partly involved in the detrimental events leading neuronal injury. [11] [12] [13] In fact, CaM antagonists such as W-7 and calmidazolium have neuroprotective effects on NMDA-induced neuronal cell death 14) and trifluoperazine reduced infarct volume in transient focal cerebral ischemia. 15) Similarly, FK-506, an immunosuppressant inhibiting calcineurin, exerts neuroprotective actions in glutamate neurotoxity. 16) Since neuronal nitric oxide synthase (nNOS) knockout mice showed a reduced infarct size following brain ischemia, nNOS underlies detrimental events in the brain ischemia. 17) We recently introduced a novel calmodulin antagonist, DY9760e, having a potent inhibitory effect on Ca 2ϩ /calmodulindependent nNOS. 18, 19) DY-9760e rescues neurons from the ischemia/reperfusion-induced neuronal death with concomitant inhibition of NO production during ischemia/reperfusion in the gerbil hippocampus. 20) Ischemia/reperfusion-induced neuronal injury is also triggered by peroxynitrite (ONOO Ϫ ), which is formed by the rapid reaction of NO with superoxide (O 2 Ϫ ). 21) The protein tyrosine nitration during ischemia/ reperfusion was also prevented by DY-9760e treatment in the gerbil ischemic brain. 20) Thus, the detrimental effects of NO and protein tyrosine nitration were defined in the ischemia/ reperfusion-induced neuronal injury. However, the detrimental effects of NO production and protein tyrosine formation have not been documented in the permanent occlusion-induced neuronal injury.
In the present study, we measured NO production by microdialysis method and protein tyrosine nitration by immunoblotting in a permanent occlusion model using microsphere. We also documented whether a novel NO inhibitor, DY-9760e, ameliorates neuronal injury induced by ME in rat.
MATERIALS AND METHODS
All procedures for handling animals were approved by the Animal Experimentation Committee of Tohoku University Graduate School of Pharmaceutical Sciences. Male Wistar rats, weighing 220-270 g, were housed at 21-24°C and maintained on a standard diet and water ad libitum.
Induction of Ischemia DY-9760e (Daiichi Pharmaceutical Co., Tokyo, Japan) dissolved in 5% glucose was admin- Dextran via a 26-G needle into the left common carotid artery, where they were visualized flowing into the internal carotid artery. After injection, the needle point was repaired by adhesive agent (alonalpha), the skin was closed. Sham-operated control group underwent identical experimental procedures with injection of equal (0.3 ml) volume of 20% Dextran solution.
Determination of Infarct Area
Eight to eleven rats were treated with vehicle or DY-9760e as described above. After 72 h of ME-induced cerebral ischemia, the rats were killed by decapitation under anesthesia. The brain was removed and chilled in ice-cold 0.32 M sucrose buffer for 3 min and followed by cut into 2-mm coronal sections. Then, the sections were stained with 2% TTC for 30 min at 37°C, and then fixed in 10% formalin solution for 4-6 h. Each brain slice was scanned and the infarct area was evaluated using Scion image software. Analyses were performed by one of the authors unaware of the treatment history of the rats.
Microdialysis Measurement of NO x ؊ Levels Microdialysis measurement of NO x Ϫ (NO 2 Ϫ and NO 3 Ϫ ) levels was performed as described previously. 18) Briefly, rats were anesthetized as above, and the head was placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, U.S.A.). A microdialysis probe (Eicom, Kyoto, Japan) was perpendicularly implanted into the left striatum (5 mm posterior and 2.5 mm lateral to the bregma, 6 mm below the brain surface) and secured with Ringer's solution at a constant rate of 1 ml/min with the microsyringe pump (ESP-64; Eicom, Kyoto, Japan). The perfused dialysates were collected every 10 min in the sample loop of an auto-injector connected to an automated NO detector-HPLC system (Eicom, Kyoto, Japan). Administration of halothane was discontinued, and animals awoke from anesthesia and were permitted to move freely. After a stabilization period of 90 min, rats were anesthetized as above and intraperitoneally administrated with the vehicle or DY-9760e, and induction of ischemia was performed 30 min later. Halothane anesthesia was again discontinued after ischemia and microdialysis under freely moving conditions was continued for 120 min. The microdialysis probe was then removed from the rats under short anesthesia, and the guide cannula remained fixed on the skull. The rats were returned to a home cage and allowed to take food and water ad libitum. To monitor NO production in the sub-acute stage, the microdialysis probe was reimplanted in the same rats under short anesthesia at 22 and 46 h, and microdialysis was also performed under freely moving condition. The perfused dialysates collected every 10 min from 24 to 25 h and 48-49 h afterward to measure NO x Ϫ levels. In each experimental group, four to six animals were studied. The NO x Ϫ levels are expressed as percentage of basal levels. Western Blot Analysis Immunoblot analyses were performed as described previously. 20) Briefly, equal amount of proteins (20 mg) was separated on 10-15% SDS-PAGE gels and transferred to PVDF membrane (Millipore Corporation, Bedford, MA, U.S.A.). After blocking in 5% non-fat milk, the blots were incubated overnight at 4°C with monoclonal anti-nitrotyrosine antibody (1 :1000; Upstate Biotechnology, Lake Placid, NY, U.S.A.), followed by anti-mouse IgG conjugated to HRP (1 :5000; Amersham Pharmacia Biotech, Arlington Heights, IL, U.S.A.). The signals were detected with a chemiluminescence kit (Amersham Pharmacia Biotech, Arlington Heights, IL, U.S.A.) and exposed on X-ray film. To quantitate the intensity of immunoreactive bands, western blots were scanned and analyzed using Image Gauge (Fujifilm, Tokyo, Japan)
Statistical Analysis Data are expressed as meanϮS.D. and were analyzed using ANOVA followed by Scheffe's test. pϽ0.05 was considered statistically significant.
RESULTS

Effect of DY-9760e on Infarct Area
To determine whether DY-9760e exerts neuroprotective effect in ME-induced cerebral ischemia model, we first investigated its effects on the infarct area 3 d after ME. ME caused infarction mainly in the striatum, thalamus, cortex and hippocampus (Fig. 1) . DY-9760e significantly reduced the infarct area when administrated twice at a dose of 12.5 mg/kg (Fig. 1) . Like ischemia/reperfusion model in gerbils, DY-9760e exhibited a neuroprotective effect on ME-induced infarction in rats.
Effect of DY-9760e on NO Production after ME We have previously demonstrated that DY-9760e inhibited Ca 2ϩ /calmodulin-dependent NOS activity in vitro 18) and NO production during ischemia/reperfusion in gerbil ischemic model. 19) To address whether NO production is implicated in ME-induced ischemic cell death, we investigated changes in NO levels after ME induction using in vivo brain microdialysis and evaluated effect of DY-9760e on the NO production. The basal levels of NO x Ϫ in dialysate obtained from the striatum were not significantly different with or without DY9760e treatment. The levels of NO x Ϫ in the sham-operated rats were stable over a period of 120 min. In the vehicletreated ME rats, the levels of NO x Ϫ significantly increased immediately after infusion of microsphere as compared to the sham group and quickly returned to the basal level within 30 min (Fig. 2A) . In a sub-acute stage at 24 and 48 h after ME, the NO x Ϫ levels further increased to 260 and 200% of the basal level, respectively (Fig. 2B) . In the acute stage, pretreatment with DY-9760e totally inhibited the elevated NO x Ϫ levels to near basal level ( Fig. 2A) . Similarly, in the subacute stage, the increases in NO x Ϫ level at 24 and 48 h were also prevented completely by DY-9760e treatment (Fig. 2B) . These results indicated that NO is produced in the ME-induced permanent occlusion, especially in the sub-acute stage and the inhibition of NO production by DY-9760e treatment accounts for its neuroprotective effect.
Protein Tyrosine Nitration Formation after ME Protein tyrosine nitration reflects formation of peroxynitrate (ONOO Ϫ ), which is formed by rapid reaction of NO with superoxide and is thought to mediate NO-triggered cell injury. 22, 23) Whether the permanent occlusion induced superoxide production like ischemia/reperfusion model is unclear. To dissolve the question, we measured protein tyrosine nitration in the ME model. Like gerbil ischemia/reperfusion model, approximately 62 kDa protein was detected as a major tyrosine nitration protein. Unlike gerbil ischemia/reperfusion model in which an increase in protein tyrosine nitration was seen only immediately after reperfusion, 20) the significant elevation of protein tyrosine nitration was not observed immediate after ME induction. Conversely, a marked elevation in the protein tyrosine nitration was seen in the sub-acute stage such as 6-48 h after ME (Fig. 3) .
Inhibition of Protein Tyrosine Nitration Formation by DY-9760e Finally, we investigated whether DY-9760e inhibits protein tyrosine nitration after ME as seen in the ischemia/reperfusion model previously. 20) Consistent with the previous observation, DY-9760e treatment completely inhibited protein tyrosine nitration after ME in a dose-dependent manner (Fig. 4) . These results suggest that inhibition of protein tyrosine nitration by DY-9760e contribute to its neuroprotective effects in this model.
DISCUSSION
We recently reported that DY-9760e, a novel CaM antagonist, had a neuroprotective effect against delayed neuronal death induced by ischemia/reperfusion models, such as transient and permanent focal ischemia in rat and transient forebrain ischemia in gerbils. 24, 25) In the present study, we addressed the question whether NO production and protein tyrosine nitration were induced by a permanent occlusion model using microsphere. In the gerbil ischemia/reperfusion model, NO elevation was persistent over the basal level at least until 120 min after ischemia. In contrast, the elevation of NO production was relatively weak and only transient immediately after ME. However, a marked increase in the NO production was seen in 24 and 48 h after ME similar to ischemia/reperfusion model. In addition, the marked increase in the protein tyrosine nitration was unexpectedly observed in the ME model. Since the permanent occlusion without reperfusion is believed to produce less superoxide than ischemia/reperfusion model, we speculated the ME could not produce protein tyrosine nitration unlike ischemia/reperfusion model. In this context, the marked increase in protein tyrosine nitration may underlie the mechanism of neuronal injury following ME. However, the precise mechanisms of increased protein tyrosine nitration as well as NO production in the sub-acute stage (6-48 h) in the ME model were unclear in the present study. The increased NO production after 24 and 48 h is thought to play a role in the persistent increase in protein tyrosine nitration.
In the present study, we also demonstrated that DY-9760e exerted neuroprotective effect on a permanent occlusion model. Because this model revealed a prolonged decrease in the cerebral blood flow and subsequently produced small and multi-infarct areas, 26) the neuronal damages caused by ME may share some biochemical and morphological events in human cerebral blood vessel occlusive dementia or multi-infarct dementia. Indeed, ME-induced ischemic damage leads to learning and memory deficits. 27) In addition, an increased proteins tyrosine nitration was evident in the pathological brain tissues including Alzheimer's disease, amyotrophic lateral sclerosis, and ischemic brain in human. [28] [29] [30] These observations suggested that the persistent increase in protein tyrosine nitration is not only a maker for pathological events in these diseases, but also is causative in neuronal death. Protein tyrosine nitration and concomitant dysfunctions of proteins have been reported during ischemia/reperfusion conditions in various tissues. For example, inactivation of manganese superoxide dismutase by tyrosine nitration occurred in rat renal ischemia/reperfusion injury. 31) Furthermore, 3-nitrotyrosine, released from nitrated proteins by peroxynitrite, contributes to vascular endothelial dysfunction and neurotoxicity through promotion of DNA damage. 32) Since DY-9760e reduced infarct size in this model with concomitant inhibition of NO and protein tyrosine nitration, DY-9760e may improve the ME-induced memory deficits in the same model.
In summary, DY-9760e ameliorates ischemic brain damage induced by ME, and the neuroprotective effects may be mediated in part by inhibition of NO production and protein tyrosine nitration. Further studies are needed to assess precise mechanism underlying neuroprotective effect through inhibition of protein tyrosine nitration and to evaluate improvement of memory deficit by DY-9760e in the ME model.
